Picture of Inogen logo

INGN — Inogen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Inogen Inc expected to post a loss of 42 cents a share - Earnings Preview

* Inogen Inc  INGN.OQ   INGN.O  is expected to show a rise
in
quarterly revenue when it reports  results on November 2. 
    * The Goleta California-based  company is expected to report
 a
5.0% increase in revenue to $97.725 million from $93.11 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. The company's guidance on August 4
2022, for the period ended September 30, was for revenue between
$97.00 million and $100.00 million.
    * ​Refinitiv's mean analyst estimate for Inogen Inc is for a
loss
of 42 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Inogen Inc
is
$37.5​, above​ its last closing price of $22.59. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.37       -0.37      -0.15     Beat    59.5
 Mar. 31 2022  -0.52       -0.51      -0.62     Missed  -21.8
 Dec. 31 2021  -0.72       -0.73      -1.01     Missed  -38.6​
 Sep. 30 2021  -0.31       -0.26      0.53      Beat    303.8
 ​​Jun.        -0.10       -0.11      0.22      Beat    300
 30 2021                                                
 Mar. 31 2021  -0.26       -0.27      -0.03     Beat    88.8​
 Dec. 31 2020  -0.26       -0.26      -0.23     Beat    12.1
 Sep. 30 2020  0.00        -0.02      -0.08     Missed  -290.2
 This summary was machine generated October 31 at 16:27 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Inogen

See all news